Preventive Medicine Doctors in East Lansing, MI Accepting Medicare

3 Preventive Medicine doctors found. Showing 1 - 3

Dr. Kenneth Daniel Rosenman, M.D. Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 4650 S Hagadorn Rd Ste 100, East Lansing, MI 48823 Phone: 517-353-4830    Fax: 517-355-2134

Edward R Rosick, D.O. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 804 Service Rd, A235, East Lansing, MI 48824 Phone: 517-355-1300    Fax: 517-355-1710

Margaret J. Byers, D.O. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3164 Hamlet Cir, East Lansing, MI 48823 Phone: 517-898-7650    Fax: 517-898-7650

News Archive

Don't hold back: five is the right age to start school

Children markedly older in their year group tend to be less motivated in high school and academically behind children who are age appropriate, new research from the University of Sydney shows.

Recommended supplementation not sufficient to normalise vitamin D levels in RA patients: Study

Two separate studies have shown that vitamin D deficiency is common in patients with a range of rheumatic diseases, with over half of all patients having below the 'normal' healthy levels of vitamin D (48-145 nmol/L) in their bodies. A further study assessing response to vitamin D supplementation found that taking the recommended daily dose did not normalise vitamin D levels in rheumatic disease patients.

Decline of obesity in pre-school kids: Study

According to a new study from the Deakin University, obesity in Victorian pre-school children has dropped. Results have shown that rates of obese and overweight toddlers fell by more than 3 per cent for three-and-a-half year olds, down from 18.5 per cent to 15.4 per cent. For two-year-olds rates have dropped 1 per cent to 12.4 per cent.

Frontline teamwork, safety practices slice hospital infection rate by 40%

Implementation of the Comprehensive Unit-based Safety Program has reduced the rate of central line-associated bloodstream infections by 40% in more than 1100 US intensive care units, reports the agency that funded the program.

CeNeRx commences TriRima Phase II trial for treatment resistant depression

CeNeRx BioPharma, today reported that it has initiated a Phase II trial of its new formulation of TriRima, the company's novel antidepressant in development as monotherapy for treatment resistant depression.

Read more Medical News

› Verified 9 days ago